MNKD


MannKind Corporation (MNKD) Announces Stock and Note Exchange Agreements With Holders of Outstanding 5.75% Senior Convertible Notes

MannKind Corporation (NASDAQ:MNKD) announced that it has entered into separate, privately-negotiated exchange agreements with select holders of its existing 5.75% Senior Convertible Notes due …

MannKind Corporation (MNKD) Weekly IMS Rx Update

MannKind (NASDAQ:MNKD) shares are down 5.54% at $5.

Biotech Beat: XOMA Corp (XOMA), Synergy Pharmaceuticals Inc (SGYP), MannKind Corporation (MNKD), CIGNA Corporation (CI)

XOMA Corp Stock Starts To Recover XOMA Corp (NASDAQ:XOMA) had an incredibly rough day in the market yesterday. After announcing that a recent Phase 3 …

Biotech Beat: MannKind Corporation (MNKD), Synergy Pharmaceuticals Inc (SGYP), Novogen Limited (NVGN) News

MannKind Corporation (NASDAQ:MNKD) stock is having a great day in the market today. When it comes to MNKD, one big concern for several …

Biotech Beat: MannKind Corporation (MNKD), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP), Biocept Inc (BIOC)

Well, the Greek Debt Crisis has come to a conclusion, a default; and US stocks seem to be back to normal. This leaves …

What Can Investors Expect From MannKind Corporation (MNKD) Moving Forward

After a bullish run that lasted about 3 weeks, MannKind Corporation (NASDAQ:MNKD) has had a tough week in the market this week. However, as …

Thursday Insights: MannKind Corporation (MNKD), Plasmatech Biopharmaceuticals Inc (PTBI), Tokai Pharmaceuticals Inc (TKAI), Box Inc (BOX)

MannKind Corporation (NASDAQ:MNKD) shares are tumbling 6.87% in mid-day trading to $5.

Jefferies Shines Light on MannKind Corporation Following Positive Physician Feedback on Afrezza (MNKD)

Jefferies analyst Shaunak Deepak weighed in with his opinions on MannKind Corporation (NASDAQ:MNKD), following positive feedback from physicians from the American Diabetes Association on the Diabetes …

Monday Morning Pre-Market Insights: MannKind Corporation (MNKD), Seadrill Ltd (SDRL), Receptos Inc (RCPT), Plasmatech Biopharmaceuticals Inc (PTBI)

MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …

Stock Update (NASDAQ:MNKD): MannKind Corporation to Present at Upcoming Conferences

MannKind Corporation (NASDAQ:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced that it will present at upcoming conferences. Jefferies 2015 Global …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts